Expression of potassium channel isoforms mRNA in normal human adrenals and aldosterone-secreting adenomas

Journal of Endocrinological Investigation

Volumn 29, Issue 2, 2006, Pages 147-153

  Sarzani, R ^a,c   Pietrucci, F ^a   Francioni, M ^a   Salvi, F ^a   Letizia, C ^b   D'Erasmo, E ^b   Dessi Fulgheri P ^a   Rappelli, A ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

Aldosterone secreting adenomas; KCNE1; KCNQ1

Indexed keywords

ALDOSTERONE; COMPLEMENTARY DNA; ISOPROTEIN; MESSENGER RNA; POTASSIUM CHANNEL KCNE1; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

ADRENAL CORTEX ADENOMA; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; AMINO ACID SEQUENCE; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC CODE; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; MALE; NUCLEOTIDE SEQUENCE; POTASSIUM CURRENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SOMATIC MUTATION;

EID: 33645555927     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03344088     Document Type: Article

References (29)

1. Davies E, Bonnardeaux A, Plouin PF, Corvol P, Clauser E. Somatic mutations of the angiotensin II (AT1) receptor gene are not present in aldosterone-producing adenoma. J Clin Endocrinol Metab 1995, 82: 611-5.
2. Romey G, Attali B, Chouabe C, et al. Molecular mechanism and functional significance of the MinK control of the KvLQT1 channel activity. J Biol Chem 1997, 272: 16713-6.
3. + channels subunits. Trends Pharmacol Sci 2000, 21: 199-201.
4. Sarzani R, Opocher G, Dessì Fulgheri P, et al. Expression of type 1 angiotensin II receptors in human aldosteronomas. Endoc Res 1995, 21: 189-95.
5. Mazzocchi G, Malendowicz LK, Markowska A, Albertin G, Nussdorfer G. Role of adrenal renin - angiotensin system in the control of aldosterone secretion in sodium restricted rats. American Journal of Physiology. Am J Physiol Endocrinol Metab 2000, 278: E1027-30.
6. Sarzani R, Opocher G, Paci MV, et al. Natriuretic peptides receptors in human aldosterone-secreting adenomas. J Endocrinol Invest 1999, 22: 514-8.
7. Sarzani R, Salvi F, Pietrucci F, et al. Absence of somatic mutations in natriuretic peptide receptor type-A gene in human aldosterone-secreting adenomas. J Mol Endocrinol 2003, 31: 317-26.
8. Parma J, Duprez L, Van Sande J, et al. Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365: 649-51.
9. Parma J, Duprez L, Van Sande J, et al. Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 1997, 82: 2695-701.
10. Ballare E, Mantovani S, Lania A, et al. Activating mutations of the Gsα gene are associated with low levels of Gsα protein in growth hormone secreting tumors. J Clin Endocrinol Metab 1997, 80: 4184-8.
11. Casimiro MC, Knollmann BC, Ebert SN, et al. Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen syndrome. Proc Natl Acad Sci U S A 1998: 2526-31.
12. Sanguinetti MC, Curran ME, Zou A, et al. Coassembly of K(v)LQT1 and minK (lsK) proteins to form cardiac l(Ks) potassium channel. Nature 1996, 84: 80-3.
13. Suessbrich H, Busch AE. The lsk channel: coassembly onf lsk (minK) and KVLQT1 proteins. Rev Physiol Biochem Pharmacol 1999, 137: 191-26.
14. Arrighi I, Bloch-Faure M, Grahammer F, et al. Altered potassium balance and aldosterone secretion in a mouse model of human congenital long QT syndrome. Proc Natl Acad Sci U S A 2001, 98: 8792-7.
15. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three Long QT Syndromes genes: KVLQT1, HERG and KCNE1. Genomics 1998, 51 86-97.
16. Barhanin J, Lesage F, Guillemare E, Fink M, Lazdunski M, Romey G 1996 K(v)LQT1 and lsK (minK) proteins associate to form the l(Ks) cardiac potassium current. Nature 1996, 384: 78-80.
17. Murray A, Donger C, Fenske C, et al. Splicing mutations in KCNQ1: a mutation hot spot at codon 344 that produces in frame transcripts. Circulation 1999, 100: 1077-84.
18. Demolombe S, Baró I, Péréon Y, et al. A dominant negative isoform of the long QT syndrome 1 gene product. J Biol Chem 1998, 273: 6837-43.
19. Jiang M, Tseng-Crank J, Tseng GN. Suppression of slow delayed rectifier current by a truncated isoform of KVLQT1 cloned from normal human heart. J Biol Chem 1997, 272: 24109-12.
20. Yang WP, Levesque PC, Little WA, Conder ML, Shalaby FY, Blanar MA. KvLQT1, a voltage-gated potassium channel responsible for human cardiac arrhythmias. Proc Natl Acad Sci U S A 1997, 94: 4017-21.
21. Sarzani R, Fallo F, Dessì Fulgheri P, et al. Local renin - angiotensin system in human adrenals and aldosteronomas. Hypertension 1992, 19: 702-7.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162: 156-9.
23. Sarzani R, Pietrucci F, Francioni M, et al. Human aldosterone secreting adenoma specifically express dominant negative KCNQ1 isoform 2 mRNA. Hypertension 2003, p.638 (abstract).
24. + channels inhibits adhesion ad proliferation of hepatocarcinoma cells. Int J Mol Med 2003, 11: 261-6.
25. Abdul M, Santo A, Hoosein N. Activity of potassium channel-blockers in breast cancer. Anticancer Res 2003, 23: 3347-51.
26. Crociani O, Guasti L, Balzi M, et al. Cell cycle-dependent expression of HERG1 and HERG1B isoforms in tumor cells. J Biol Chem 2003, 278: 2947-55.
27. Abdul M, Hoosein N. Expression and activity of potassium ion channels in human prostate cancer. Cancer Lett 2002, 186: 99-105.
28. Abdul M, Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol Rep 2002, 9: 961-4.
29. + channels of human lung cancer cells. Eur J Pharmacol 2002, 435: 125-33.